$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

From Warburg effect to Reverse Warburg effect; the new horizons of anti-cancer therapy

Medical hypotheses, v.144, 2020년, pp.110216 -   

Benny, Sonu (Corresponding author.) ,  Mishra, Rohan ,  Manojkumar, Maneesha K ,  Aneesh, T.P.

Abstract AI-Helper 아이콘AI-Helper

Abstract An old ideology of killing the cancer cells by starving them is the underlying concept of the Warburg effect. It is the process of aerobic glycolysis exhibited by the cancer cells irrespective of anaerobic glycolysis or mitochondrial oxidative phosphorylation following by their healthy cou...

주제어

참고문헌 (76)

  1. J Cancer Res Warburg 9 148 1925 10.1158/jcr.1925.148 The metabolism of carcinoma cells 1 

  2. Cancer Biol Ther Zhang 14 81 2013 10.4161/cbt.22958 Altered energy metabolism in cancer: A unique opportunity for therapeutic intervention 

  3. 10.1007/s10549-018-4691-4 Welch HG. The heterogeneity of cancer. vol. 169; 2018. https://doi.org/10.1007/s10549-018-4691-4. 

  4. Biomed Res Int Avagliano 2018 2018 10.1155/2018/6075403 Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts 

  5. Trends Cell Biol Hinohara 29 569 2019 10.1016/j.tcb.2019.03.003 Intratumoral Heterogeneity: More Than Just Mutations 

  6. Oncotarget Fu 8 57813 2017 10.18632/oncotarget.18175 The reverse Warburg effect is likely to be an Achilles’ heel of cancer that can be exploited for cancer therapy 

  7. J Mol Med Dang 89 205-12 2011 Therapeutic targeting of cancer cell metabolism 

  8. 10.1038/nrd3504 Heiden MG vander. Targeting cancer metabolism: a therapeutic window opens. Nature Publishing Group; 10:671-84. https://doi.org/10.1038/nrd3504. 

  9. Cell Cycle Martinez-Outschoorn 10 4208 2011 10.4161/cc.10.24.18487 Energy transfer in “parasitic” cancer metabolism: Mitochondria are the powerhouse and Achilles’ heel of tumour cells 

  10. J Oncol Sci Fadaka 3 45 2017 10.1016/j.jons.2017.06.002 Biology of glucose metabolization in cancer cells 

  11. Sign Trans Targeted Therapy Hu 2 1 2017 Central role of lactate and proton in cancer cell resistance to glucose deprivation and its clinical translation 

  12. Front Nutrit Goodwin 1 2014 2015 Lactate and Cancer: Revisiting the Warburg Effect in an Era of Lactate Shuttling 

  13. Front Pharmacol Porporato 2011 10.3389/fphar.2011.00049 Anticancer targets in the glycolytic metabolism of tumours: A comprehensive review 

  14. World J Biol Chem Lee 2015 10.4331/wjbc.v6.i3.148 Metabolic interplay between glycolysis and mitochondrial oxidation: the reverse Warburg effect and its therapeutic implication 

  15. Mol Carcinog Nakajima 2013 10.1002/mc.21863 Metabolic symbiosis in cancer: Refocusing the Warburg lens 

  16. Trends Cell Biol Manchester 5 384 1995 10.1016/S0962-8924(00)89080-7 Theodor Boveri and the origin of malignant tumours 

  17. Science Warburg 123 309 1956 10.1126/science.123.3191.309 On the origin of cancer cells 

  18. Science Heiden 324 1029 2009 10.1126/science.1160809 Understanding the Warburg effect: The metabolic requirements of cell proliferation 

  19. Carcinogenesis San-Millan 38 119 2017 Re-examining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect 

  20. Cancer Res Kim 66 8927-30 2006 Cancer’s molecular sweet tooth and the Warburg effect 

  21. Pharmacol Ther Upadhyay 137 318 2013 10.1016/j.pharmthera.2012.11.003 The Warburg effect: Insights from the past decade 

  22. Proteomics Clin Appl Scatena 2010 10.1002/prca.200900157 Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy 

  23. Biochim et Biophys Acta - Bioenergetics Danhier 1858 556 2017 10.1016/j.bbabio.2017.02.001 Cancer metabolism in space and time: Beyond the Warburg effect 

  24. Front Cell Dev Biol Bubici 7 1 2019 10.3389/fcell.2019.00080 Editorial: The Warburg effect regulation under siege: The intertwined pathways in health and disease 

  25. Mol Cancer Jing 18 1 2019 10.1186/s12943-019-1089-9 Role of hypoxia in cancer therapy by regulating the tumour microenvironment 

  26. Toxicol Res Tran 32 177 2016 10.5487/TR.2016.32.3.177 Targeting cancer metabolism - revisiting the Warburg effects 

  27. Int J Radiat Biol Vaupel 95 912 2019 10.1080/09553002.2019.1589653 The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression 

  28. Semin Nephrol Spencer 2019 10.1016/j.semnephrol.2019.04.007 The Warburg Effect, Lactate, and Nearly a Century of Trying to Cure Cancer 

  29. Cell Cycle Pavlides 8 3984 2009 10.4161/cc.8.23.10238 The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumour stroma 

  30. Cell Cycle Whitaker-Menezes 2011 10.4161/cc.10.11.15659 Evidence for a stromal-epithelial “lactate shuttle” in human tumours 

  31. Semin Oncol Wilde 44 198 2017 10.1053/j.seminoncol.2017.10.004 Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development 

  32. Cell Cycle Witkiewicz 11 1108 2012 10.4161/cc.11.6.19530 Using the “reverse Warburg effect” to identify high-risk breast cancer patients: Stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers 

  33. J Exercise Physiol Online Crisp 18 1 2015 Lactate and Monocarboxylate Transporters (MCTs): A Review of Cellular Aspects 

  34. PLoS Comput Biol Shan 14 1 2018 10.1371/journal.pcbi.1006584 Multi-scale computational study of the Warburg effect, reverse Warburg effect and glutamine addiction in solid tumours 

  35. Int J Radiat Oncol*Biol*Phys Boasquevisque 99 E579 2017 10.1016/j.ijrobp.2017.06.1994 Targeting Lactate Transporters MCT-1 and MCT-4 to Inhibit the Growth of Hypoxic HNSCC Cells In Vitro 

  36. Cell Reprogramm Mordhorst 2018 10.1089/cell.2017.0040 Pharmacologic Reprogramming Designed to Induce a Warburg Effect in Porcine Fetal Fibroblasts Alters Gene Expression and Quantities of Metabolites from Conditioned Media Without Increased Cell Proliferation 

  37. DMM Disease Mod Mechan Draoui 4 727 2011 10.1242/dmm.007724 Lactate shuttles at a glance: From physiological paradigms to anti-cancer treatments 

  38. Mol Cells Lee 39 847 2016 10.14348/molcells.2016.0310 Cancer metabolism: Fueling more than just growth 

  39. Pleura Peritoneum Wilson 4 1 2019 10.1515/pp-2019-0003 Resistance to anoikis in transcoelomic shedding: the role of glycolytic enzymes 

  40. Mol Cancer Ther Quanz 17 2285 2018 10.1158/1535-7163.MCT-17-1253 Preclinical efficacy of the novel monocarboxylate transporter 1 inhibitor BAY-8002 and associated markers of resistance 

  41. Int J Green Pharm Aneesh 3 184 2009 10.4103/0973-8258.56271 International market scenario of traditional Indian herbal drugs - India declining 

  42. Int J Nanotechnol Sonal 2 1 2012 Nanomedicine: Promise Of The Future In Disease Management 

  43. J Clin Diagnos Res Sreelatha 12 2018 Prolonged remission and good quality of life with maintenance chemotherapy in recurrent ewing’s sarcoma 

  44. The Global Cancer Observatory G. Source: Globocan 2018. World Health Organization 2019; 876: 2018-9. 

  45. International Agency for Research on Cancer (IARC). New Global Cancer Data: GLOBOCAN 2018 | UICC. Geneva, Switzerland, 12 September 2018; 2018: 1-3. 

  46. Mol Cancer Ther Todenhofer 17 2746 2018 10.1158/1535-7163.MCT-18-0107 Selective inhibition of the lactate transporter MCT4 reduces growth of invasive bladder cancer 

  47. 10.1073/pnas.95.7.3990 Pellerin L, Pellegri G, Martin JL, Magistretti PJ. Expression of monocarboxylate transporter mRNAs in mouse brain: Support for a distinct role of lactate as an energy substrate for the neonatal vs. adult brain. Proceed Natl Acad Sci USA 1998; 95:3990-5. https://doi.org/10.1073/pnas.95.7.3990. 

  48. Acta Biomedica Chiu 83 168 2012 Towards a metabolic therapy of cancer? 

  49. Int J Mol Sci Roma-Rodrigues 20 2019 10.3390/ijms20040840 Targeting tumor microenvironment for cancer therapy 

  50. ISRN Biochemistry Tsai 2014 1 2014 10.1155/2014/351959 Tumor Microenvironment: A New Treatment Target for Cancer 

  51. Transl Oncol Zhong 13 57 2020 10.1016/j.tranon.2019.10.001 Targeting Tumor Microenvironment by Small- Molecule Inhibitors 

  52. Indian J Dermatol, Venereol Leprol Jose 80 82 2014 10.4103/0378-6323.125486 Revisiting cutaneous metastasis from carcinoma gall bladder 

  53. Front Oncol Morrot 8 1 2018 10.3389/fonc.2018.00081 Metabolic symbiosis and immunomodulation: How tumor cell-derived lactate may disturb innate and adaptive immune responses 

  54. Biomol Therapeut van Dang 26 4 2018 10.4062/biomolther.2017.194 Convergence of cancer metabolism and immunity: An overview 

  55. Eur Rev Med Pharmacol Sci Wang 22 3855 2018 Tumor microenvironment: Recent advances in various cancer treatments 

  56. Science Hodge 5 363 1990 The Metabolic Requirements of Cell Proliferation 

  57. J Thora Oncol Kobayashi 2 808 2007 10.1097/JTO.0b013e31814617c7 Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less 

  58. Cancer Therapy Adv Blevins Primeau 1 2018 A. Cancer recurrence statistics 

  59. Tumor Microenviron Therapy Takebe 1 2013 10.2478/tumor-2013-0001 Review of Cancer - Associated Fibroblasts and Therapies that Interfere with Their Activity 

  60. Adv Exp Med Biol Sazeides 2018 10.1007/978-3-319-77736-8_11 Metabolic relationship between cancer-associated fibroblasts and cancer cells 

  61. J Exp Clin Cancer Res Yoshida 34 1 2015 10.1186/s13046-015-0221-y Metabolic reprogramming: The emerging concept and associated therapeutic strategies 

  62. Biochim et Biophys Acta - Mol Cell Res Perez-Escuredo 2016 10.1016/j.bbamcr.2016.03.013 Monocarboxylate transporters in the brain and in cancer 

  63. Asian-Australasian J Anim Sci Parkunan 30 246 2017 10.5713/ajas.16.0020 Changes in expression of monocarboxylate transporters, heat shock proteins and meat quality of Large White Yorkshire and Ghungroo pigs during hot summer period 

  64. Cancer Genom Proteom Gorska-Ponikowska 14 483 2017 2-Methoxyestradiol Reverses the Pro-Carcinogenic Effect of L-Lactate in Osteosarcoma 143B Cells 

  65. Sci Rep da Veiga 9 1 2019 Metabolic therapies inhibit tumor growth in vivo and in silico 

  66. Mol Aspects Med Halestrap 34 337 2013 10.1016/j.mam.2012.05.003 The SLC16 gene family-Structure, role and regulation in health and disease 

  67. Cancer Cell Int Guo 19 1 2019 10.1186/s12935-019-0889-8 Monocarboxylate transporter 1 and monocarboxylate transporter 4 in cancer-endothelial co-culturing microenvironments promote proliferation, migration, and invasion of renal cancer cells 

  68. PLoS Biol Haas 13 2015 10.1371/journal.pbio.1002202 Lactate regulates metabolic and proinflammatory circuits in control of T cell migration and effector functions 

  69. 10.1016/B978-0-12-394316-3.00009-0 Adijanto J, Philp NJ. The SLC16A family of monocarboxylate transporters (MCTs)-physiology and function in cellular metabolism, pH homeostasis, and fluid transport. vol. 70. Elsevier; 2012. doi: 10.1016/B978-0-12-394316-3.00009-0. 

  70. Anticancer Res Gotanda 33 2941 2013 Expression of monocarboxylate transporter (MCT)-4 in colorectal cancer and its role: MCT4 contributes to the growth of colorectal cancer with vascular endothelial growth factor 

  71. BMC Clin Pathol Latif 17 1 2017 10.1186/s12907-017-0067-7 Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer 

  72. Oncol Rev Javaeed 13 88 2019 10.4081/oncol.2019.403 MCT4 has a potential to be used as a prognostic biomarker - A systematic review and meta-analysis 

  73. Mol Membr Biol Manoharan 2006 10.1080/09687860600841967 The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activity 

  74. ACS Med Chem Lett Gurrapu 6 558 2015 10.1021/acsmedchemlett.5b00049 Monocarboxylate transporter 1 inhibitors as potential anticancer agents 

  75. Cancer Res Gallagher 2007 10.1158/0008-5472.CAN-06-3184 Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231 

  76. Clin Exp Metastasis Chen 2010 10.1007/s10585-010-9345-9 Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로